Results of Flow Cytometric Analysis of Samples From 17 Patients With ATL
| Case . | Age/Sex . | Type . | Material . | % Positive Cells . | ||||
|---|---|---|---|---|---|---|---|---|
| . | . | . | . | CD3 . | CD4 . | Tac . | OX40 . | gp34 . |
| 1 | 38/F | Acute | PB | 92.3 | 85.5 | 83.6 | 64.5 | NE |
| 2 | 65/M | Acute | PB | 74.1 | 86.3 | 87.4 | 39.6 | NE |
| 3 | 56/M | Acute | PB | 81.3 | 84.9 | 80.9 | 0 | 0.7 |
| 4 | 61/M | Acute | PB | 75.6 | 85.7 | 76.9 | 64.8 | 0 |
| 5 | 39/F | Acute | PB | 84.9 | 88.4 | 85.1 | 46.2 | 1.1 |
| 6 | 72/F | Acute | LN | 87.6 | 94.8 | 87.6 | 83.4 | 0.6 |
| 7 | 71/M | Acute | PB | 81.2 | 61.7 | 80.4 | 47.7 | 2.1 |
| 8 | 51/F | Acute | PB | 65.8 | 78.2 | 68.3 | 26.4 | 0.4 |
| 9 | 72/M | Chronic | PB | 97.9 | 96.3 | 94.7 | 85.3 | NE |
| 10 | 40/M | Chronic | PB | 68.2 | 80.9 | 74.0 | 0 | 0 |
| 11 | 49/F | Chronic | PB | 71.0 | 67.5 | 45.9 | 40.5 | 0 |
| 12 | 46/F | Chronic | PB | 86.3 | 84.1 | 56.8 | 70.9 | 1.9 |
| 13 | 37/M | Chronic | PB | 98.6 | 94.8 | 46.1 | 81.0 | 1.6 |
| 14 | 54/M | Chronic | LN | 73.3 | 61.8 | 20.4 | 46.1 | 0 |
| 15 | 56/M | Chronic | PB | 85.8 | 85.6 | 38.1 | 85.9 | 2.4 |
| 16 | 54/M | Lymphomatous | ST | 90.1 | 85.2 | 55.9 | 26.1 | 3.5 |
| 17 | 65/F | Lymphomatous | LN | 94.6 | 90.6 | 34.5 | 46.7 | 0.9 |
| Case . | Age/Sex . | Type . | Material . | % Positive Cells . | ||||
|---|---|---|---|---|---|---|---|---|
| . | . | . | . | CD3 . | CD4 . | Tac . | OX40 . | gp34 . |
| 1 | 38/F | Acute | PB | 92.3 | 85.5 | 83.6 | 64.5 | NE |
| 2 | 65/M | Acute | PB | 74.1 | 86.3 | 87.4 | 39.6 | NE |
| 3 | 56/M | Acute | PB | 81.3 | 84.9 | 80.9 | 0 | 0.7 |
| 4 | 61/M | Acute | PB | 75.6 | 85.7 | 76.9 | 64.8 | 0 |
| 5 | 39/F | Acute | PB | 84.9 | 88.4 | 85.1 | 46.2 | 1.1 |
| 6 | 72/F | Acute | LN | 87.6 | 94.8 | 87.6 | 83.4 | 0.6 |
| 7 | 71/M | Acute | PB | 81.2 | 61.7 | 80.4 | 47.7 | 2.1 |
| 8 | 51/F | Acute | PB | 65.8 | 78.2 | 68.3 | 26.4 | 0.4 |
| 9 | 72/M | Chronic | PB | 97.9 | 96.3 | 94.7 | 85.3 | NE |
| 10 | 40/M | Chronic | PB | 68.2 | 80.9 | 74.0 | 0 | 0 |
| 11 | 49/F | Chronic | PB | 71.0 | 67.5 | 45.9 | 40.5 | 0 |
| 12 | 46/F | Chronic | PB | 86.3 | 84.1 | 56.8 | 70.9 | 1.9 |
| 13 | 37/M | Chronic | PB | 98.6 | 94.8 | 46.1 | 81.0 | 1.6 |
| 14 | 54/M | Chronic | LN | 73.3 | 61.8 | 20.4 | 46.1 | 0 |
| 15 | 56/M | Chronic | PB | 85.8 | 85.6 | 38.1 | 85.9 | 2.4 |
| 16 | 54/M | Lymphomatous | ST | 90.1 | 85.2 | 55.9 | 26.1 | 3.5 |
| 17 | 65/F | Lymphomatous | LN | 94.6 | 90.6 | 34.5 | 46.7 | 0.9 |
The percentage of positive cells was determined by immunofluorescence staining and flow cytometric analysis.
Abbreviations: NE, not examined; PB, peripheral blood; LN, lymph node; ST, subcutaneous tumor.